HALISTER: Novartis to Acquire Rights to Glaxo MS Drug for Up to $1 Billion - Halister News

HALISTER: Novartis to Acquire Rights to Glaxo MS Drug for Up to $1 Billion

Novartis to Acquire Rights to Glaxo MS Drug for Up to $1 Billion

Alert: HALISTER
Source: BN (Bloomberg News)

Tickers
GSK LN (GlaxoSmithKline PLC)
NOVN VX (Novartis AG)

To de-activate this alert, click here
To modify this alert, click here

UUID: 7947283

Download x-rimdevice-bloomberg-news-nlrt.blp